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Objective
We hypothesized that an assessment of myocardial scar-
ring by cardiac magnetic resonance (CMR) would
improve risk stratification.
Background
Current sudden cardiac death (SCD) risk stratification
emphasizes left-ventricular ejection fraction (LVEF),
however the majority of patients suffering SCD have a
preserved LVEF and many with poor LVEF do not bene-
fit from ICD prophylaxis.
Methods
One hundred thirty-seven patients undergoing evalua-
tion for possible ICD placement were prospectively
enrolled and underwent CMR assessment of LVEF and
scar. A comprehensive medical history including CAD
risk factors, heart failure functional class (NYHA), and
medications at the time of CMR was obtained in all
patients. A total of 105 (77%) patients underwent EPS
within a median of 0 days (IQR 0, 3.5) of CMR. No
patient experienced a change in clinical status in the
time between CMR and EPS. 103 patients (75%) had an
ICD placed, generally during the initial evaluation,
2 days (IQR 1, 7) after enrollment.
Results
During a median follow-up of 24 months, 39 patients
experienced the prespecified primary endpoint of death
or appropriate ICD discharge for sustained ventricular
tachyarrhythmia. Whereas the rate of adverse events
steadily increased with decreasing LVEF, a sharp step-up
was observed for scar size >5% of LV mass (HR=5.2 [95%
CI, 2.0-13.3]). On multivariable Cox proportional hazards
analysis, including LVEF and electrophysiological-study
results, scar size (as continuous variable or dichotomized
at 5%) was an independent predictor of adverse outcome.
Among patients with LVEF >30%, those with significant
scarring (>5%) had higher risk than those with minimal-
or-no (less than or equal to 5%) scarring (HR=6.3 [1.4-
28.0]). Those with LVEF >30% and significant scarring
had similar risk to patients with LVEF less than or equal
to 30% (p=0.56). (Figure 1) Among patients with LVEF
less than or equal to 30%, those with significant scarring
again had higher risk than those with minimal-or-no
scarring (HR=3.9 [1.2-13.1]). Those with LVEF less than
or equal to 30% and minimal scarring had similar risk to
patients with LVEF >30% (p=0.71). (Figure 2)
Conclusions
Myocardial scarring detected by CMR is an independent
predictor of adverse outcome in patients being consid-
ered for ICD placement. In patients with preserved
LVEF, significant scarring (>5% LV) identifies a high-
risk cohort similar in risk to those with LVEF less than
or equal to 30%. Conversely, in patients with LVEF less
than or equal to 30%, minimal-or-no scarring identifies
a low-risk cohort similar to those with preserved LVEF.
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